Brief: Nuformix Announces Confirmation Of European Orphan Drug Designation
30/04/2025 08:05
April 30 (Reuters) - Nuformix PLC NFXN.L: NUFORMIX PLC - CONFIRMATION OF EUROPEAN ORPHAN DRUG DESIGNATION Source text: ID:nRSd7159Ga Further company coverage: NFXN.L ((Reuters.Briefs@thomsonreuters.com;))